To investigate the association between NBAT1 expression and clinical characteristics, GC patients were divided into two groups: the low NBAT1 expression group (n=44, fold-change ≤2) and the high NBAT1 expression group (n=34, fold-change ≥2). This evidence concerns the gene NBAT1 and gastric cancer.